Pembrolizumab Plus Radiation and Surgery Improves DFS in Soft Tissue Sarcoma
home / oncclub / pembrolizumab-plus-radiation-and-surgery-improves-dfs-in-soft-tissue-sarcoma
Yvonne Mowery, MD, PhD, discusses the phase 2 SU2C-SARC032 trial (NCT03092323) investigating the addition of pembrolizumab (Keytruda) to preoperative radiotherapy and surgery in patients with soft tissue sarcoma.